Insulin Pen Injectors
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Research Report 2023
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Aspirin
1.2.3 Ibuprofen
1.2.4 Naproxen
1.2.5 Celecoxib
1.2.6 Others
1.3 Market by Application
1.3.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Drug Store
1.3.3 Hospital Pharmacies
1.3.4 Online
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Perspective (2017-2028)
2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Trends by Region
2.2.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Region (2017-2022)
2.2.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Region (2023-2028)
2.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Dynamics
2.3.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry Trends
2.3.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers
2.3.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges
2.3.4 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Revenue
3.1.1 Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Revenue (2017-2022)
3.1.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Players (2017-2022)
3.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue
3.4 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio
3.4.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2021
3.5 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players Head office and Area Served
3.6 Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Solution and Service
3.7 Date of Enter into Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Breakdown Data by Type
4.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Type (2017-2022)
4.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2023-2028)
5 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Breakdown Data by Application
5.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Application (2017-2022)
5.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2017-2028)
6.2 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022)
6.3 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2017-2028)
7.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022)
7.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2017-2028)
8.2 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022)
8.3 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2017-2028)
9.2 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022)
9.3 Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2017-2028)
10.2 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022)
10.3 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Roche (Genentech)
11.1.1 Roche (Genentech) Company Detail
11.1.2 Roche (Genentech) Business Overview
11.1.3 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.1.4 Roche (Genentech) Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.1.5 Roche (Genentech) Recent Development
11.2 Amgen
11.2.1 Amgen Company Detail
11.2.2 Amgen Business Overview
11.2.3 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.2.4 Amgen Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.2.5 Amgen Recent Development
11.3 B-MS
11.3.1 B-MS Company Detail
11.3.2 B-MS Business Overview
11.3.3 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.3.4 B-MS Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.3.5 B-MS Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.4.4 Merck Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.4.5 Merck Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.5.4 Pfizer Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.5.5 Pfizer Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.6.4 Novartis Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.6.5 Novartis Recent Development
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Company Detail
11.7.2 Eli Lilly and Company Business Overview
11.7.3 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.7.4 Eli Lilly and Company Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.7.5 Eli Lilly and Company Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Detail
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.8.4 Johnson & Johnson Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.8.5 Johnson & Johnson Recent Development
11.9 GSK
11.9.1 GSK Company Detail
11.9.2 GSK Business Overview
11.9.3 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.9.4 GSK Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.9.5 GSK Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Detail
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.10.4 Sanofi Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.10.5 Sanofi Recent Development
11.11 Boehringer Ingelheim
11.11.1 Boehringer Ingelheim Company Detail
11.11.2 Boehringer Ingelheim Business Overview
11.11.3 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.11.4 Boehringer Ingelheim Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.11.5 Boehringer Ingelheim Recent Development
11.12 Zhejiang Jiuzhou Pharmaceutical
11.12.1 Zhejiang Jiuzhou Pharmaceutical Company Detail
11.12.2 Zhejiang Jiuzhou Pharmaceutical Business Overview
11.12.3 Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
11.12.4 Zhejiang Jiuzhou Pharmaceutical Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
11.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Aspirin
Table 3. Key Players of Ibuprofen
Table 4. Key Players of Naproxen
Table 5. Key Players of Celecoxib
Table 6. Key Players of Others
Table 7. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region (2017-2022)
Table 11. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region (2023-2028)
Table 13. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Trends
Table 14. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers
Table 15. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges
Table 16. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints
Table 17. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players (2017-2022)
Table 19. Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) as of 2021)
Table 20. Ranking of Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Solution and Service
Table 24. Date of Enter into Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2017-2022)
Table 28. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2023-2028)
Table 30. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2017-2022)
Table 32. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2023-2028)
Table 34. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2023-2028) & (US$ Million)
Table 44. Roche (Genentech) Company Detail
Table 45. Roche (Genentech) Business Overview
Table 46. Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 47. Roche (Genentech) Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 48. Roche (Genentech) Recent Development
Table 49. Amgen Company Detail
Table 50. Amgen Business Overview
Table 51. Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 52. Amgen Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 53. Amgen Recent Development
Table 54. B-MS Company Detail
Table 55. B-MS Business Overview
Table 56. B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 57. B-MS Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 58. B-MS Recent Development
Table 59. Merck Company Detail
Table 60. Merck Business Overview
Table 61. Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 62. Merck Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 63. Merck Recent Development
Table 64. Pfizer Company Detail
Table 65. Pfizer Business Overview
Table 66. Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 67. Pfizer Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 68. Pfizer Recent Development
Table 69. Novartis Company Detail
Table 70. Novartis Business Overview
Table 71. Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 72. Novartis Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 73. Novartis Recent Development
Table 74. Eli Lilly and Company Company Detail
Table 75. Eli Lilly and Company Business Overview
Table 76. Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 77. Eli Lilly and Company Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 78. Eli Lilly and Company Recent Development
Table 79. Johnson & Johnson Company Detail
Table 80. Johnson & Johnson Business Overview
Table 81. Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 82. Johnson & Johnson Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 83. Johnson & Johnson Recent Development
Table 84. GSK Company Detail
Table 85. GSK Business Overview
Table 86. GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 87. GSK Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 88. GSK Recent Development
Table 89. Sanofi Company Detail
Table 90. Sanofi Business Overview
Table 91. Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product
Table 92. Sanofi Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 93. Sanofi Recent Development
Table 94. Boehringer Ingelheim Company Detail
Table 95. Boehringer Ingelheim Business Overview
Table 96. Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)Product
Table 97. Boehringer Ingelheim Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 98. Boehringer Ingelheim Recent Development
Table 99. Zhejiang Jiuzhou Pharmaceutical Company Detail
Table 100. Zhejiang Jiuzhou Pharmaceutical Business Overview
Table 101. Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)Product
Table 102. Zhejiang Jiuzhou Pharmaceutical Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022) & (US$ Million)
Table 103. Zhejiang Jiuzhou Pharmaceutical Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type: 2021 VS 2028
Figure 2. Aspirin Features
Figure 3. Ibuprofen Features
Figure 4. Naproxen Features
Figure 5. Celecoxib Features
Figure 6. Others Features
Figure 7. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application in 2021 & 2028
Figure 8. Drug Store Case Studies
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Online Case Studies
Figure 11. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Report Years Considered
Figure 12. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region: 2021 VS 2028
Figure 15. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players in 2021
Figure 16. Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2021
Figure 18. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2017-2028)
Figure 20. United States Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2017-2028)
Figure 24. Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region (2017-2028)
Figure 32. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. South Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Australia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2017-2028)
Figure 40. Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2017-2028)
Figure 44. Turkey Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Roche (Genentech) Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 47. Amgen Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 48. B-MS Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 49. Merck Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 50. Pfizer Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 51. Novartis Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 52. Eli Lilly and Company Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 53. Johnson & Johnson Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 54. GSK Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 55. Sanofi Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 56. Boehringer Ingelheim Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 57. Zhejiang Jiuzhou Pharmaceutical Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2017-2022)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche (Genentech) Amgen B-MS Merck Pfizer Novartis Eli Lilly and Company Johnson & Johnson GSK Sanofi Boehringer Ingelheim Zhejiang Jiuzhou Pharmaceutical